Rigel Pharmaceuticals recently issued full-year 2026 guidance, projecting total revenue of about US$275 million to US$290 million, including US$255 million to US$265 million in net product sales and ...

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is one of the Best Performing Affordable Stocks Under $40. On January 12, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) released its preliminary results for the ...

Hi, everyone. My name is Denise Liu. I am an associate on the health care investment banking team here. So we're excited to be continuing the 44th Annual Healthcare Conference this afternoon, and it ...

Rigel Pharmaceuticals has benefitted from Tavalisse's sustained outperformance, driving increasing net income and attractive valuation metrics. Gavreto's recent flat performance is offset by RIGL's ...

Rigel Pharmaceuticals (RIGL) is scheduled to announce Q3 earnings results on Tuesday, November 4th, after market close. The consensus EPS Estimate is $0.79 and the consensus Revenue Estimate is ...

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology.

Virginia State Police on Wednesday released more information about the man who died after jumping off the Route 288 bridge into the James River.